Cipher Pharmaceuticals

company

About

A rapidly growing specialty pharmaceutical dermatology company with a diversified portfolio of commercial-stage products

  • 51 - 100

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$20M
Industries
Health Care,Medical,Pharmaceutical
Founded date
Jan 1, 2000
Number Of Employee
51 - 100
Operating Status
Active

Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs. They search for products in defined markets to in-license into our pipeline. These products are based on currently marketed molecules paired with a novel drug delivery technology for enhanced performance. Their core competency is identifying these product opportunities and managing their clinical and regulatory development. Finally, we harvest the rewards by out-licensing to partners and generating royalty streams.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$20M
Cipher Pharmaceuticals has raised a total of $20M in funding over 2 rounds. Their latest funding was raised on Nov 3, 2017 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 3, 2017 Post-IPO Debt $20M 1 CIBC Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Cipher Pharmaceuticals is funded by 1 investors. CIBC are the most recent investors.
Investor Name Lead Investor Funding Round
CIBC Yes Post-IPO Debt